Monsanto's venture capital arm disappears after Bayer acquisition For the agricultural behemoth Monsanto, which this month finalized its $66 billion deal with the chemical giant Bayer, one of those sacrifices is saying goodbye to a venture-capital team that kept the company on the cutting edge of food and farm tech. (Business Insider)